Skip to Content
  • Abstract
  • Open Access

30 September 2022

2 Pages

Chemopreventive Potential of Santolina chamaecyparissus against MNU-Induced Mammary Cancer in Female Wistar Rats †

,
,
,
,
,
,
and
1
Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
2
Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
3
Department of Genetics and Biotechnology, School of Life and Environmental Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
4
Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal

Abstract

Breast cancer is the most often diagnosed cancer worldwide, with the greatest fatality rate among women in 2021. Santolina chamaecyparissus L. has been shown to successfully inhibit cancer cells’ proliferation, especially in the human breast adenocarcinoma (MCF-7) cell line. This study’s goal was to evaluate the chemopreventive potential of a S. chamaecyparissus aqueous extract (SCE) on N-methyl-N-nitrosourea (MNU)-induced mammary cancer in female rats. This study was approved by the ORBEA under reference 834-e-CITAB-2020. Twenty-eight four-week-old female Wistar rats were divided into four groups: Control, MNU, SCE and SCE+MNU. SCE was supplemented in drinking water (120 µg/mL) ad libitum and replaced every 3 days due to the compounds’ stability. A total of nineteen compounds were identified in the extract, with myricetin-O-glucuronide and 1,3-O-dicaffeoylquinic acid being the main compounds found. At 50 days of age, the MNU was administered by intraperitoneal route. Humane Endpoint analysis was performed weekly. Induced animals were palpated twice a week. Tumour width (W) and length (L) were weekly measured with a calliper. Tumour volume was also determined [V = (W2 × L)/2]. After twenty-one weeks, animals were sacrificed by a ketamine/xylazine overdose. Control and SCE animals did not develop any tumours. In the MNU group, the first tumour appeared during the ninth week; in SCE+MNU, it only appeared in the sixteenth week. No significant differences were found. However, the tumour incidence in SCE+MNU (28.57%) was lower than in MNU (57.14%). The MNU group had a higher mean tumour weight (2.31 ± 1.13 g) than the SCE+MNU group (0.39 ± 0.02 g) and a larger mean tumour volume (2.02 ± 1.23 cm3) than SCE+MNU (0.57 ± 0.15 cm3) (p > 0.05). Despite the lack of statistically significant differences between groups, the absence of mortality in SCE+MNU, as well as the lower values in each parameter, suggest that Santolina chamaecyparissus has interesting potential as a chemoprotective agent. Histopathological analysis will help understand this extract’s impact on oncogenesis.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/Foods2022-12981/s1.

Author Contributions

Methodology and writing—original draft: T.A.; Investigation—T.A., J.S.; A.V.; L.A. and T.C.F.; conceptualization, supervision and project administration: L.B., M.M. and P.A.O. All authors have read and agreed to the published version of the manuscript.

Funding

The authors acknowledge the financial support by the Portuguese Foundation for Science and Technology (FCT) through a Doctoral Grant (2020.07999.BD, J.S.), and through national funds FCT/MCTES (PIDDAC) to CITAB (UIDB/04033/2020), CIMO (UIDB/00690/2020 and UIDP/00690/2020) and SusTEC (LA/P/0007/2021); L.B. thanks to the national funding by FCT through the institutional scientific employment program–contract for her contract.

Institutional Review Board Statement

This study was approved by an Ethics Review Body (“ORBEA—Órgão Responsável pelo Bem-Estar e Ética Animal” under reference 834-e-CITAB-2020.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.